China's drugmakers can't sell mRNA shots but haven't quit yet | WKZO | Everything Kalamazoo

By Andrew Silver SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by ...

Related Keywords

Shanghai ,China ,Malaysia ,Australia ,Indonesia ,Laos ,Suzhou ,Jiangsu ,Jakarta ,Jakarta Raya ,Beijing ,Malaysian ,Chinese ,Abogen Biosciences ,Robert Langer ,George Gao ,Dicky Budiman ,Stanley Widianto ,Frank Zhang ,Ying Bo ,Li Hangwen ,Kongxay Phounphenghack ,Davone Duangdany ,Andrew Silver ,Michele Gershberg ,Sonali Paul ,Reuters ,Chinese Center ,Child Health Center ,Griffith University ,World Health Organization ,Chinese Academy Of Sciences Institute Microbiology ,Walvax Biotechnology ,Stemirna Therapeutics ,Chinese Academy ,Sciences Institute ,Chinese Center For Disease Control ,Malaysia Pharmaniaga ,